Mr. Kameel Farag joined the BioVie Board of Directors in 2025. Most recently, he served as Chief Financial Officer, Treasurer, and Head of Business Operations at Aspen Neuroscience, where, under his direction, the company tripled its headcount, secured more than $150 million in financing, and built the foundations for future clinical milestones and a potential IPO. During his tenure as Senior Vice President of Finance at Ionis Pharmaceuticals, he strengthened financial operations to support rapid growth and previously spent over 16 years at Amgen in senior international finance roles, including Chief Financial Officer of the Intercontinental Region. Mr. Farag holds a BA in Business & Economics from the University of California, Santa Barbara.